Compulsory licensing of patents

被引：0

作者：

Kumutha, Narayanasamy ^{[1
]}

Amutha, Narayanasamy ^{[1
]}

Venkatesh, Govindasamy S. ^{[2
]}

机构：

[1] MAAS Res Solut LLP, Patent Agent, Madurai, Tamil Nadu, India

[2] Periyar Maniammai Inst Sci & Technol, Dept EEE, Thanjavur, Tamil Nadu, India

来源：

PHARMACEUTICAL PATENT ANALYST | 2022年 / 11卷 / 06期

关键词：

compulsory licensing; Nexavar; TRIPS;

D O I：

10.4155/ppa-2022-0039

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Compulsory licensing (CL) is a mechanism made by the government to provide balance between the monopoly right holders and the third person with public interest by ensuring the ease availability of the patented products at reasonable rate. This paper discusses the background criteria for getting CL in India as per the Indian Patent Act, 1970 starting from the concepts outlined in the Trade-Related Aspects of Intellectual Property Rights agreement. We reviewed the case studies for the accepted and rejected CL in India. We also discuss important CL cases that were permitted internationally, including the present COVID pandemic CL. Finally, we provide our analytical perspectives regarding the pros and cons of CL.

引用

页码：225 / 231

页数：7

共 18 条

[1]

[Anonymous], 1970, Indian Patent Act of

[2] Compulsory licensing and interim measures in Merck: a case for Italy or for antitrust law? [J].

Coco, Rita ;

Nebbia, Paolisa .

JOURNAL OF INTELLECTUAL PROPERTY LAW & PRACTICE, 2007, 2 (07) :452-462

[3]

Essential Inventions Inc, RE PET US AUTH BAYH

[4]

European Patent Office, [No title captured], Patent No. [T1150/15, 151150]

[5]

Health Affairs, EX MARCH IN RIGHTS W, DOI [10.1377/forefront.20220331.198909, DOI 10.1377/FOREFRONT.20220331.198909]

[6]

Intellectual Property India, 2008, Indian patent, Patent No. 215758

[7]

Intellectual Property India, 2007, Indian patent, Patent No. 206543

[8]

Intellectual Property India, 2007, Indian patent, Patent No. 203937

[9]

ipindia, INTELLECTUAL PROPERT

[10]

Knowledge Ecology International, 2010, 2010 FABR MARCH REQ

← 1 2 →